Kuzemko J A, Lines J G
Arch Dis Child. 1970 Apr;45(240):215-20. doi: 10.1136/adc.45.240.215.
Adrenal cortical function was assessed in 20 children receiving 2·5 to 10 mg. prednisolone daily, by measuring plasma cortisol levels before and after the administration of the synthetic polypeptide β, tetracosactrin (Synacthen). 18 of the children were asthmatics, one had nephrosis, and one had dermatomyositis. Adrenal function was classified as (a) abnormal response to tetracosactrin, where basal plasma cortisol and post-tetracosactrin levels did not exceed 6 μg./100 ml.; (b) partial response, where there was a rise of 5-10 μg./100 ml. in plasma cortisol following tetracosactrin but the basal levels (< 10 μg./100 ml.) were below or only slightly above the lower normal limit; (c) normal response, where there was usually at least a doubling of the basal value and an incremental increase of at least 10 μg./100 ml. in the plasma cortisol concentrations following tetracosactrin. All 6 children receiving the higher dosage of 10 mg. prednisolone daily had abnormal adrenal function. 4 receiving the lower dosage of 2·5 mg./day had satisfactory adrenal reserve. Of the 10 children receiving the intermediate dosage of 5 mg. prednisolone daily, 2 had frankly abnormal adrenocortical function, 3 had poor adrenal reserve, and 5 produced good incremental values, though their baseline cortisol levels were low. At the 5 mg. prednisolone dose adrenocortical suppression was not correlated either with duration of therapy or with age.
对20名每日服用2.5至10毫克泼尼松龙的儿童进行了肾上腺皮质功能评估,方法是在给予合成多肽β - 二十四肽促皮质素(辛纳科)前后测量血浆皮质醇水平。其中18名儿童患有哮喘,1名患有肾病,1名患有皮肌炎。肾上腺功能分为以下几类:(a)对二十四肽促皮质素反应异常,即基础血浆皮质醇和注射二十四肽促皮质素后的水平不超过6微克/100毫升;(b)部分反应,即注射二十四肽促皮质素后血浆皮质醇升高5 - 10微克/100毫升,但基础水平(<10微克/100毫升)低于或仅略高于正常下限;(c)正常反应,即通常基础值至少翻倍,且注射二十四肽促皮质素后血浆皮质醇浓度增量至少增加10微克/100毫升。所有6名每日接受10毫克较高剂量泼尼松龙治疗的儿童肾上腺功能均异常。4名每日接受2.5毫克较低剂量治疗的儿童肾上腺储备良好。在10名每日接受5毫克中等剂量泼尼松龙治疗的儿童中,2名肾上腺皮质功能明显异常,3名肾上腺储备较差,5名虽然基线皮质醇水平较低,但产生了良好的增量值。在5毫克泼尼松龙剂量下,肾上腺皮质抑制与治疗持续时间或年龄均无相关性。